Loading stock analysis…
Evidence Synthesis
Last synthesized: 22 Aug 2026, 00:15
See how this stock's evidence score moved across recent sessions — unlock Pro for the live chart.
Full momentum history unlocks with Pro or Research.
Evidence Synthesis
APEX has seen a 35.24% gross margin, accelerating from 3.98%, in the latest quarterly update.
This represents a significant improvement, driven by a .98% marginal operating leverage, up from 3.45%. Revenue growth has also been strong, with a .5% year-over-year increase. The stock price has also shown upward momentum, with a .6 INR close price, up from 398.7 INR. Daily trading volume has decreased, with 224,998 shares traded, down from 371,572 shares.
Source observations behind the synthesis narrative.
| Metric | Value | Trend | |
|---|---|---|---|
| GROSS_MARGIN | 35.24 % | 3.98 | ▲ |
| MARGINAL_OPERATING_LEVERAGE | 3.98 % | 3.45 | ▲ |
| REVENUE_GROWTH_YOY | 14.5 % | — | - |
| PRICE_CHANGE_PERCENT | 0.226 % | — | - |
| DAILY_VOLUME | 2,24,998 shares | 3,71,572 | ▼ |
| CLOSE_PRICE | 399.6 INR | 398.7 | ▲ |